Intrapericardial Amiodarone for the Prevention of Postoperative Atrial Fibrillation

Journal of Cardiac Surgery
Louay M Habbab, F Victor Chu

Abstract

Despite probably being the most effective prophylactic drug for postoperative atrial fibrillation (POAF), amiodarone is reserved as a second-line agent because of its potential systemic side effects. Herein, we review the available experimental and clinical trials examining the effectiveness of intrapericardial (IPC) amiodarone administration in preventing POAF which, if confirmed by future studies, can have a significant impact on cardiac surgery practice.

References

Mar 1, 1989·Progress in Cardiovascular Diseases·M S LauerR W DeSanctis
Mar 1, 1987·Canadian Journal of Physiology and Pharmacology·J F BrienP W Armstrong
Apr 1, 1984·Journal of the American College of Cardiology·D P ZipesJ J Heger
Sep 1, 1984·The Medical Clinics of North America·J J HegerD P Zipes
Sep 1, 1993·The Annals of Thoracic Surgery·L L CreswellJ L Cox
Jul 1, 1997·Cardiovascular Research·I KodamaJ Toyama
Nov 14, 1997·Annals of Surgery·G H AlmassiK E Hammermeister
Feb 25, 1998·Pacing and Clinical Electrophysiology : PACE·M Jafari-Fesharaki, M M Scheinman
Feb 2, 2000·The Annals of Thoracic Surgery·C W Hogue, M L Hyder
Dec 19, 2001·Annals of Internal Medicine·W H MaiselW G Stevenson
Oct 8, 2003·The Annals of Thoracic Surgery·Wolfgang F KonertzJon E Block
Mar 5, 2004·Journal of the American College of Cardiology·Rollo P VillarealAli Massumi
Apr 15, 2004·JAMA : the Journal of the American Medical Association·Joseph P MathewUNKNOWN Multicenter Study of Perioperative Ischemia Research Group
Oct 31, 2006·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Joel DunningUNKNOWN EACTS Audit and Guidelines Committee
Sep 20, 2007·JAMA : the Journal of the American Medical Association·Patricia Vassallo, Richard G Trohman
Jan 15, 2008·International Journal of Cardiology·A John Camm
Feb 26, 2008·Journal of the American College of Cardiology·Najmeddine EchahidiPatrick Mathieu
Feb 24, 2009·Aesthetic Surgery Journal·Xiao Zhibo, Zhang Miaobo
Aug 25, 2009·Journal of Cardiovascular Pharmacology·Robert W BoldermanJos G Maessen
Mar 6, 2010·International Journal of Cardiology·Robert W BoldermanJos G Maessen
Apr 7, 2010·The Journal of Thoracic and Cardiovascular Surgery·Robert W BoldermanJos G Maessen
Mar 1, 2011·The Annals of Thoracic Surgery·Takahide TakedaRyuzo Sakata
Aug 22, 2013·Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society·M MaaroosT Hakala
Dec 25, 2013·The Heart Surgery Forum·Juan MarcanoWilliam E Cohn
Jul 22, 2014·The Journal of Thoracic and Cardiovascular Surgery·Xiao Dong FengWilliam Wang
Jan 21, 2015·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Kevin PhanTristan D Yan
Aug 10, 2015·The Journal of Thoracic and Cardiovascular Surgery·William WangXiao Dong Feng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.